Julie Appleby reports on the implementation of the health care overhaul law, the interplay of health care treatments and costs, trends in health insurance, and policy issues affecting hospitals and other medical providers. Her KHN stories have appeared in USA Today, the Washington Post, the Philadelphia Inquirer and MSNBC, among others. Before joining KHN in March 2009, Appleby spent 10 years on the health care industry and policy beat for USA Today. She also worked at the San Francisco Chronicle
, the Financial Times
in London and the Contra Costa Times
in Walnut Creek, Calif. She serves on the board of the Association of Health Care Journalists and her education includes a Master of Public Health degree. | Contact: JulieA@kff.org | @Julie_Appleby
Many are encouraging the use of less-costly regimens and paying the same for drugs, whether they’re given in hospital outpatient settings or doctors’ offices.
Expert panels suggest those with less serious liver disease wait for drugs in development.
But experts say it’s too early to draw conclusions about the impact on premiums.
Even estranged spouses must generally file joint returns to get subsidies for health coverage, putting them at potential risk.
The price tag of the breakthrough treatment raises questions about the proper costs of pharmaceuticals.
The administration pressed the pause button on part of the health law again. Here's what the new timeline for the employer mandate means for businesses, workers -- and for politicians.
For nearly 3 million Americans, subsidies don’t kick in until they’ve paid up to 9.5% of their income toward premiums.
Former Health And Human Services Secretary Michael Leavitt says officials could learn from similar, albeit smaller, problems he and his staff had implementing the Medicare Prescription Drug Program in 2006, and that he doubts the Obama administration will meet its goals for enrollment in the health law's insurance marketplaces.
Those buying some bronze and silver plans could have to spend thousands before full coverage kicks in.
Rule changes and deadline shifts have complicated the efforts of health insurance companies to prepare for a wave of new customers and “post-enrollment snafus.”